9:25 - 9:30 amSunday, September 18
Upper Lobby
5 principles to sustainable behavior change: a case study in non-adherence
Upper Lobby
5 principles to sustainable behavior change: a case study in non-adherence
Medisafe
Greater social support has been shown to be associated with improved health outcomes and healthier behavior Non-adherence to chronic medications imposes a substantial clinical and financial burden on the... Read more

Description

Greater social support has been shown to be associated with improved health outcomes and healthier behavior Non-adherence to chronic medications imposes a substantial clinical and financial burden on the US healthcare system. Research shows that social support using existing friends or family has been associated with greater medication adherence. A recent CVS Health report evaluated 50 peer-reviewed articles, which directly measured the connection between social support systems and medication adherence. There have been many medication reminder interventions aimed simply reminding patients to take their medications in order to increase adherence. In a new approach, Medisafe provides a personalized mHealth platform that uses its social support feature to enhance medication adherence beyond just reminders. This combination seeks to tackle the $290 billion problem of non-adherence by addressing all the major underlying causes of this complex problem, including lack of motivation and support through the app’s Medfriend feature.

The Medfriend feature allows a family member and/or caregiver, to engage in the medication adherence regimen of another user. This allows the Medfriend to assume an important role in supporting patients in managing their medication and health. When a Medisafe user adds and connects with a Medfriend, the designated caregiver receives alerts about missed medication doses and can view the user’s history and schedule. This makes the patient more accountable, encourages positive behavioral changes and helps prevent serious health events that could arise from a missed dose. The Medfriend feature was integral within Medisafe from the beginning, since a double dose of insulin threatened the health of founders Omri and Rotem Shor’s father.

The company released in the end of 2015 the results of a retrospective study demonstrating the positive effect of its Medfriend social support feature on medication adherence. The study showed that 40% of previously non-adherent users (taking their medications less than 80% of the time) became adherent (taking their medications at least 80% of the time) after adding a Medfriend. Medisafe’s study looked at the impact of the Medfriend feature on both adherence and retention:

Group One – Adherence: 1,617 users who were non-adherent before adding a Medfriend and were active two weeks before and after adding a Medfriend. 71% improved adherence after adding a Medfriend (mean=+17% improvement), and 40% became adherent after adding a Medfriend.

Group Two – Retention: 4,000 users with a Medfriend and 4,000 users without a Medfriend, all of whom must have a) installed Medisafe during a two-month period between 5/29/15 and 7/28/15 and b) registered a medication dose at least once. After 90 days on Medisafe, users with a Medfriend were 59% more likely to have remained active.

Our study results indicate that adding social support to a medication adherence intervention can yield positive results.

As EVP Marketing and
Business Development for Medisafe, Jon is responsible for consumer growth and
adoption of the company’s cloud-synced mobile medication management
platform. Jon unites 20 years of experience in digital consumer
behaviors and psychologies and a keen understanding of market dynamics to develop
and evolve innovative new healthcare products. Prior to Medisafe, Jon led
Sermo, the pioneer of physician social networking, to 40% market penetration
and prepared the service for global expansion after managing through an
acquisition by WorldOne, a leader in global healthcare market research. Jon
holds a B.A. in Economics from Tufts University and an MBA from UCLA’s Anderson
School.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search